| SYS | | r032699 |
|---|
| LBL | | ^^^^^naa^^22^^^^^^^^450^ |
|---|
| 005 | | 20130617162420.9 |
|---|
| 100 | | $a 20050414a2005 m y0sloc0103 ba |
|---|
| 101 | 0- | $a eng $d eng |
|---|
| 102 | | $a SK |
|---|
| 200 | 1- | $a Disease status in patients with chronic myeloid leukemia is better characterised by BCR-ABL/BCR transcript ratio than by BCR-ABL transcript level, which may suggest a role of normal BCR gene in the disease pathogenesis $f J. Moravcová ... [et al.] |
|---|
| 215 | | $c Grafy, obr. |
|---|
| 320 | | $a Res. angl. |
|---|
| 320 | | $a Bibliogr. odkazy |
|---|
| 463 | -1 | $1 001 sllk_un_cat*sg000148_2005_005_002 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 52, no. 2 (2005), p. 119-125 $1 210 $a Bratislava $c Veda |
|---|
| 541 | 1- | $a Chorobný stav u pacientov s chronickou myeloidnou leukémiou je lepšie charakterizovaný transkripčným pomerom BCR-ABL/BCR než hladinou BCR-ABL - keďže je možné predpokladať normálne BCR gény v priebehu patogenézy choroby |
|---|
| 606 | 1- | $3 sllk_un_auth*d015464 $a leukémia myeloidná chronická, BCR-ABL pozitívna $x diagnostika $x farmakoterapia $9 . $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d016044 $a proteíny fúzne, bcr-abl $x analýza $x použitie diagnostické $9 . $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d020133 $a reakcia polymerázová reťazová, s reverznou transkriptázou $x metódy $9 . $2 mesh |
|---|
| 606 | 2- | $a prognóza $2 mesh $3 sllk_un_auth*d011379 $9 . |
|---|
| 606 | 2- | $a metastázy nádorové $x diagnostika $2 mesh $3 sllk_un_auth*d009362 $9 . |
|---|
| 606 | 2- | $a fosfotransferázy $2 mesh $3 sllk_un_auth*d010770 $9 . |
|---|
| 675 | | $a 616.155.392-097 $v 2. $z slo |
|---|
| 701 | -1 | $a Moravcová $b J. $3 sllk_un_auth*p0051893 $4 070 $p Institute of hematology and blood transfusion, Prague |
|---|
| 701 | -1 | $a Regner $b J. $3 sllk_un_auth*p0040648 $4 070 $p Institute of hematology and blood transfusion, Prague |
|---|
| 701 | -1 | $a Moučková $b D. $3 sllk_un_auth*p0040649 $4 070 $p Institute of hematology and blood transfusion, Prague |
|---|
| 701 | -1 | $a Fišer $b K. $3 sllk_un_auth*p0040650 $4 070 $p Institute of hematology and blood transfusion, Prague |
|---|
| 701 | -1 | $a Zmeková $b V. $3 sllk_un_auth*p0040651 $4 070 $p Institute of hematology and blood transfusion, Prague |
|---|
| 701 | -1 | $a Maláčková $b R. $3 sllk_un_auth*p0040652 $4 070 $p Institute of hematology and blood transfusion, Prague |
|---|
| 701 | -1 | $3 sllk_un_auth*p0035010 $a Michalová $b Kyra $f 1942- $p Institute of hematology and blood transfusion, Prague $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*p0043371 $a Klamová $b Hana $p Institute of hematology and blood transfusion, Prague $4 070 |
|---|
| 801 | -0 | $a SK $b BA006 $c 20050414 $g AACR2 |
|---|
